Genetic Testing of 18 Hereditary Cancer CapitalBio

Name: Genetic Testing of 18 Hereditary Cancer
Brand: CapitalBio Technology Co., Ltd.

This test can provide risk assessment in high-risk groups with a family history by detecting gene mutations in the entire coding region and splice region of 64 genes associated with 18 hereditary tumors at one time.

Inquire Now

Genetic Testing of 18 Hereditary Cancer Features

	Cancer Types

Male (16)	Hereditary prostate cancer, Hereditary breast cancer, Hereditary colorectal cancer, Hereditary kidney cancer, Hereditary pancreatic cancer, Hereditary pheochromocytoma
	Hereditary gastric cancer, Hereditary familial paraganglioma, Hereditary multiple endocrine tumors, Hereditary melanoma, Hereditary chondrosarcoma, Hereditary parathyroid cancer
	Hereditary thyroid cancer, Hereditary neurofibromatosis
	Hereditary Brom's Syndrome, Hereditary retinoblastoma
Female (17)	Hereditary breast cancer, Hereditary ovarian cancer, Hereditary endometrial cancer
	Hereditary colorectal cancer, Hereditary kidney cancer, Hereditary pancreatic cancer
	Hereditary pheochromocytoma, Hereditary gastric cancer, Hereditary familial paraganglioma Hereditary multiple endocrine tumors, Hereditary melanoma, Hereditary chondrosarcoma
	Hereditary parathyroid cancer, Hereditary thyroid cancer, Hereditary neurofibromatosis
	Hereditary Brom's Syndrome, Hereditary retinoblastoma

Genetic Testing of 18 Hereditary Cancer Applicable Population

Patients with tumors, especially those with tumors diagnosed at an unusually young age, or those with tumors that occur on both sides of paired organs (eg, kidneys, breasts).
People with a family history of cancer, especially if multiple close relatives have the same type of cancer (eg, mother, daughter, sister with breast cancer).
Patients with birth defects associated with hereditary tumor syndromes, such as certain benign skin abnormalities or skeletal deformities.

Specification of Genetic Testing of 18 Hereditary Cancer

Sample types	blood
TAT	20 days

Products

Related Solutions for Anti-cancer Therapy

Individualized Medication Guidance for Cancer (118 Genes)

Targeted Medication Guidance for Lung Cancer

Related Solutions for Anti-cancer Therapy Documents

NIPT Brochure (EN)

Click To View

Fully Integrated Microfluidic Platform

Click To View